ANTHONY JACK M 4
4 · TULARIK INC · Filed Aug 17, 2004
Insider Transaction Report
Form 4
TULARIK INCTLRK
ANTHONY JACK M
Sr. VP, Bus & Commercial Dev
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2004-08-13−100,000→ 0 totalExercise: $8.73Exp: 2012-11-19→ Common Stock (100,000 underlying) - Disposition to Issuer
Common Stock
2004-08-13−358.13→ 0 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2004-08-13−17,195→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−30,000→ 0 totalExercise: $11.15Exp: 2013-09-15→ Common Stock (30,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−20,000→ 0 totalExercise: $14.80Exp: 2013-12-02→ Common Stock (20,000 underlying)
Footnotes (7)
- [F1]Total of non-derivative securities directly owned included 6,385 Tularik common shares acquired under Tularik's Employee Stock Purchase Plan on January 30, 2004.
- [F2]Disposed of pursuant to merger agreement between issuer and Amgen Inc. in exchange for 7,754 shares of Amgen common stock having a market value of $55.432 per share pursuant to the terms of the merger agreement.
- [F3]Total of non-derivative securities indirectly owned under the 401(k) Trust included 61.10 Tularik common shares acquired on March 31, 2004.
- [F4]Disposed of pursuant to merger agreement between issuer and Amgen Inc. in exchange for 161 shares of Amgen common stock having a market value of $55.432 per share pursuant to the terms of the merger agreement.
- [F5]This option, which provided for vesting as to 25,001 shares on 11/4/2003, 2,082 shares on 12/4/2003 and the remainder shares vesting monthly at a rate of 2,083.33 shares per month until all shares fully vested on 11/4/06, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 45,099 shares of Amgen common stock for $19.36 per share.
- [F6]This option, which provided for monthly vesting beginning October 16, 2003 until full vest on September 16, 2007, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 13,529 shares of Amgen common stock for $24.73 per share.
- [F7]This option, which provided for monthly vesting beginning January 3, 2004 until full vest on December 3, 2007, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 9,019 shares of Amgen common stock for $32.82 per share.